Form 4: Director Patrick Hackett Receives Outset Medical Equity

Director Patrick T. Hackett acquired 10,667 restricted stock units in Outset Medical, Inc. as part of a standard equity grant.

Summary

• Director Patrick T. Hackett was granted 10,667 restricted stock units (RSUs) on June 4, 2026.
• The shares were granted at a price of $0.00 per share.
• Following this transaction, Hackett's direct beneficial ownership increased to 105,839 shares.
• Hackett maintains additional indirect holdings of 83,333 shares in a GST Trust and 41,666 shares in the Hackett Family Fund.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The grant aligns the director's interests with long-term shareholder value through equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The RSUs are scheduled to vest on the earlier of the one-year anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize board members and align their interests with the company's long-term performance.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is a common practice among publicly traded medical device companies to ensure board retention and alignment.
• The vesting schedule tied to the annual meeting is consistent with standard industry practices for board compensation.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 10,667 RSUs on the earlier of June 4, 2027, or the date of the next Annual Meeting of Stockholders.

Key Dates

Keywords

Outset Medical, OM, Form 4, Insider Trading, Equity Grant, Director Compensation